Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.2153
-0.0053-2.40%
Post-market: 0.21960.0043+2.00%19:50 EDT
Volume:76.19K
Turnover:16.61K
Market Cap:5.49M
PE:-0.20
High:0.2230
Open:0.2230
Low:0.2136
Close:0.2206
52wk High:1.89
52wk Low:0.1593
Shares:25.48M
Float Shares:24.18M
Volume Ratio:0.41
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0878
EPS(LYR):-1.5837
ROE:-241.14%
ROA:-118.81%
PB:1.81
PE(LYR):-0.14

Loading ...

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 19

BioRestorative Therapies Delays Q2 10-Q Filing After CEO, CFO Resignations

Reuters
·
Aug 15

BioRestorative Therapies: Has not Made Decision to Discontinue Suspended Product Lines - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Conducting Review of the Documentation, Sourcing, Regulatory Status Associated with Suspended Products- SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Suspends All Orders, Shipments of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, on Aug 7 - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioRestorative Therapies Director Esha Randhawa Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Biorestorative Therapies Files Form 3 Initial Beneficial Ownership Statement for Director Steven Collier Brown

Reuters
·
Jul 25

Biorestorative Therapies - Appoints Katharyn Field as CEO, President, and Interim CFO Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative Therapies - Lance Alstodt Resigns as President, CEO, Chairman and All Other Positions Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative Therapies - Robert Kristal Resigns as CFO and All Other Positions Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative CEO Lance Alstodt, CFO Robert Kristal Resign Effective Immediately

Reuters
·
Jul 17

Biorestorative Completes Phase 2 Manufacturing for Brtx-100 Lumbar Disc Disease Trial Supply

Reuters
·
Jun 25

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform

GlobeNewswire
·
Jun 25

BioRestorative Therapies files Form 3 for director Jatinder Dhaliwal, reporting no beneficial ownership

Reuters
·
Jun 19

BioRestorative names Zachary Smith VP of biocosmeceuticals division

Reuters
·
Jun 18

BioRestorative Therapies Strengthens Leadership With Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth

THOMSON REUTERS
·
Jun 18

BioRestorative Therapies director Katharyn Field files initial beneficial ownership statement

Reuters
·
Jun 18

BioRestorative adds lender designees Grasso, Field, Dhaliwal to board after three director resignations

Reuters
·
Jun 13

BioRestorative publishes investor presentation on BRTX-100 stem cell therapy for chronic lumbar disc disease

Reuters
·
Jun 02